MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics

Area of Science:

• Endocrinology
• Human Molecular Genetics
• Oncology

Background:

• Pituitary adenomas are a common manifestation of certain endocrine neoplasia syndromes.
• Hereditary syndromes like Multiple Endocrine Neoplasia (MEN) types 1 and 4, and Carney Complex (CNC) can present with pituitary adenomas.
• These syndromes exhibit variable clinical presentations.

Purpose of the Study:

• To review the clinical features of MEN1, MEN4, and CNC.
• To explore the human molecular genetics underlying these hereditary syndromes.
• To highlight the genetic basis of pituitary adenomas within these conditions.

Main Methods:

• Review of clinical features and human molecular genetics of MEN1, MEN4, and CNC.
• Analysis of genetic mutations associated with these syndromes.
• Correlation of genotype with phenotype, including pituitary adenoma development.

Main Results:

• MEN1 is caused by inactivating mutations in the MEN1 gene, leading to features like primary hyperparathyroidism, pancreatic neuroendocrine tumors, and prolactinomas.
• MEN4 is associated with pituitary adenomas and other MEN1 features due to mutations in the CDKN1B gene.
• CNC is primarily caused by PRKAR1A gene mutations, resulting in primary pigmented nodular adrenocortical disease, myxomas, and acromegaly.

Conclusions:

• MEN1, MEN4, and CNC are autosomal dominant hereditary syndromes linked to pituitary adenomas.
• Specific gene mutations (MEN1, CDKN1B, PRKAR1A) drive distinct clinical manifestations and genetic pathways.
• Understanding the molecular genetics is crucial for diagnosing and managing these complex endocrine neoplasia syndromes.